Inventor · disambiguated record
Karen Annette Duggan
Also filed as: DUGGAN KAREN A · DUGGAN KAREN ANNETTE
17 granted patents·2 pending applications·43 citations·filing 2005–2021
91Inventor score
Top patents by PatentIndex Score
19 records- 0189US7951777B2Compositions and methods for treatment of cardiovascular diseaseVECTUS BIOSYSTEMS LTD·Filed 2005·Granted May 31, 2011·7 cites·9 claims
- 0283US9458093B2Compositions for the treatment of hypertension and/or fibrosisVECTUS BIOSYSTEMS LTD·Filed 2014·Granted Oct 4, 2016·6 cites·16 claims
- 0383US8916523B2VIP fragments and methods of useVECTUS BIOSYSTEMS LTD·Filed 2013·Granted Dec 23, 2014·5 cites·13 claims
- 0483US8569235B2Treatment of kidney disorders with VIP fragmentsDUGGAN KAREN ANNETTE·Filed 2009·Granted Oct 29, 2013·6 cites·8 claims
- 0583US8470778B2VIP fragments and methods of useDUGGAN KAREN ANNETTE·Filed 2006·Granted Jun 25, 2013·5 cites·15 claims
- 0678US9340583B2VIP fragments and methods of useVECTUS BIOSYSTEMS LTD·Filed 2014·Granted May 17, 2016·2 cites·4 claims
- 0776US10919863B2Compositions for the treatment of pulmonary fibrosisVECTUS BIOSYSTEMS LTD·Filed 2017·Granted Feb 16, 2021·1 cites·10 claims
- 0876US10035775B2Compositions for the treatment of fibrosis and fibrosis-related conditionsVECTUS BIOSYSTEMS LTD·Filed 2016·Granted Jul 31, 2018·2 cites·21 claims
- 0976US8729020B2Methods for the treatment of aortic fibrosis with VIP fragmentsDUGGAN KAREN ANNETTE·Filed 2010·Granted May 20, 2014·3 cites·7 claims
- 1073US9630935B2Compositions for the treatment of hypertension and/or fibrosisVECTUS BIOSYSTEMS LTD·Filed 2014·Granted Apr 25, 2017·2 cites·18 claims
- 1170US9238831B2Nucleic acid quantitation methodDUGGAN KAREN ANNETTE·Filed 2010·Granted Jan 19, 2016·1 cites·12 claims
- 1269US10183908B2Compositions for the treatment of kidney and/or liver diseaseVECTUS BIOSYSTEMS LTD·Filed 2016·Granted Jan 22, 2019·1 cites·17 claims
- 1369US9238054B2Treatment of kidney fibrosis with VIP fragmentsVECTUS BIOSYSTEMS PTY LTD·Filed 2013·Granted Jan 19, 2016·2 cites·8 claims
- 1466US11834417B2Compositions for the treatment of hypertension and/or fibrosisVECTUS BIOSYSTEMS LTD·Filed 2021·Granted Dec 5, 2023·0 cites·13 claims
- 1565US11401245B2Compositions for the treatment of pulmonary fibrosisVECTUS BIOSYSTEMS LTD·Filed 2021·Granted Aug 2, 2022·0 cites·6 claims
- 1658US11053202B2Compositions for the treatment of hypertension and/or fibrosisVECTUS BIOSYSTEMS LTD·Filed 2017·Granted Jul 6, 2021·0 cites·13 claims
- 1758US9732136B2VIP fragments and methods of useVECTUS BIOSYSTEMS LTD·Filed 2016·Granted Aug 15, 2017·0 cites·7 claims
- 1846US2014235541A1Compositions and methods for treatment of aortic fibrosisVECTUS BIOSYSTEMS PTY LTD·Filed 2014·Application pending·0 cites
- 1940US2016040214A1Nucleic Acid Quantitation MethodACCUGEN PTY LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karen Annette Duggan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →